XW033H7
Introduction of Axicabtagene Ciloleucel Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 7
Introduce Axicab in Periph Vein, Perc, New Tech 7
Axis Breakdown
Every ICD-10-PCS code is exactly seven characters, one per axis. Each character's meaning is defined by its position in the code.
| Position | Value | Meaning |
|---|---|---|
| 1 | SectionX | New Technology |
| 2 | Body SystemW | Anatomical Regions |
| 3 | Root Operation0 | Introduction Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products |
| 4 | Body Part3 | Peripheral Vein |
| 5 | Approach3 | Percutaneous |
| 6 | Device / Substance / TechnologyH | Axicabtagene Ciloleucel Immunotherapy |
| 7 | New Technology Group7 | New Technology Group 7 |
Potential MS-DRG Relationships (FY2026)
The MS-DRG grouper treats this as a non-operating-room procedure. It appears in the surgical logic of 1 MS-DRG:
- MDC PRE — Chimeric Antigen Receptor (CAR) T-Cell and Other Immunotherapies: DRG 018
From the CMS MS-DRG Definitions Manual, Appendix E. Actual DRG assignment depends on the complete claim.
Change history
No changes recorded for this code — unchanged since the FY2026 (April) baseline of the change ledger.